山东大学耳鼻喉眼学报

• 论文 • 上一篇    下一篇

嗅神经母细胞瘤的化疗

王进,杨伟炎,王荣光,韩东一   

  1. 解放军总医院耳鼻咽喉头颈外科,北京 100853
  • 收稿日期:1900-01-01 修回日期:1900-01-01 出版日期:2006-02-25 发布日期:2006-02-25

Chemotherapy for esthesioneuroblastoma

WANG Jin, YANG Weiyan, WANG Rongguang, HAN Dongyi   

  1. Department of Otorhinolaryngology, PLA General Hospital, Beijing 100853, China
  • Received:1900-01-01 Revised:1900-01-01 Online:2006-02-25 Published:2006-02-25

摘要: 分析影响嗅神经母细胞瘤化疗的因素并探讨嗅神经母细胞瘤的化疗方案。方法:回顾分析1993年3月至2004年6月收治的4例行化疗的嗅神经母细胞瘤患者的临床资料,包括就诊时年龄、性别、病程、Kadish分期、组织病理学分级、治疗方式、预后,并对文献进行复习。结果:4例均为男性,平均31.5岁,Kadish分期均为C期。组织病理学分级:2级1例,3级2例,4级1例。化疗药物4例含有足叶乙甙、3例含有铂类药物。化疗在首次治疗中应用1例(病理2级随访6个月,带瘤生存),挽救治疗中应用3例(2例病理3级分别随访48个月、6个月无瘤生存,1例病理4级随访12个月带瘤生存)。结论:嗅神经母细胞瘤治疗采用化疗有效,组织病理学分级影响肿瘤对化疗的敏感性,化疗宜采用含铂类及足叶乙甙的多种药物。

关键词: 嗅神经母细胞瘤, 药物治疗, 铂, 依托泊甙

Abstract: Objective: To analyze the impact of chemotherapy on esthesioneuroblastoma and illustrate the suitable chemotherapy modality. Methods: A retrospective chart review of patients with esthesioneuroblastoma treated with chemotherapy at our department from Mar. 1993 to Jun. 2004, including age, gender, duration, Kadish staging, Hymas grade,therapy modality and outcome, was analyzed. Results: Four male cases, averagely aged 31.5 years, were treated. All patients were in Kadish C stage, and 1 in Hymas grade 2, 2 in Hymas grade 3, and 1 in Hymas grade 4. The main components of chemical drug included etoposide and platin. Chemotherapy was used as primary therapy on 1 case with grade 2, and the patient was still alive with tumor at the end of followup of 6 months. Chemotherapy was used on 3 cases as salvage therapy. Among them, 2 cases with grade 3 were alive without tumor after followups of 48 months and 6 months respectively, and 1 case with grade 4 was alive with tumor after followup of 12 months. Conclusions: Adoption of chemotherapy to treat esthesioneuroblastoma is effective, and the Hymas grade of esthesioneuroblastoma affects the response to chemotherapy. The components of chemical drug should include etoposide and platin.

Key words: Drug therapy, Platinum, Esthesioneuroblastoma, Etoposide

[1] 张彩霞,刘阳云,江文,刘庚勋,曹杭,陈琼,张纪帅. 一氧化氮对鼻咽癌CNE-2细胞株化疗增敏效应的研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 72-78.
[2] 史丽,赵莉,张红萍. 变应性鼻炎的长期抗炎治疗[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 9-12.
[3] 许昱,陶泽璋. 重视变应性鼻炎药物治疗的规范化和个体化[J]. 山东大学耳鼻喉眼学报, 2017, 31(3): 4-8.
[4] 章如新. 变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 3-6.
[5] 张革化,李文婷. 变应性鼻炎的药物治疗策略[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 10-14.
[6] 吴青松,曾蓉,刘明娜,洪潮鑫,刘绪光,邓伟锋,周凤平. 慢性鼻-鼻窦炎患者药物治疗的生存质量及相关研究[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 26-30.
[7] 何景春1,阮清伟2,韩淼淼1,金斌1,李克勇1,董频1. 应用顺铂建立C57小鼠感音神经性聋模型的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(1): 1-5.
[8] 程雷. 变应性鼻炎的诊断和治疗[J]. 山东大学耳鼻喉眼学报, 2013, 27(2): 1-4.
[9] 李姝娜,王晓宇,姜学钧 . 离体培养时bFGF对顺铂耳蜗毒性的拮抗作用[J]. 山东大学耳鼻喉眼学报, 2007, 21(5): 423-426 .
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!